Boothbay Fund Management »

Y Mabs Therapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Y Mabs Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Y Mabs Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Y Mabs Therapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.6M 347k 16.26
2023-09-30 $85k 16k 5.45
2021-09-30 $219k 7.7k 28.51
2021-06-30 $268k 7.9k 33.77

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ishares Bitcoin Tr SHS
Fidelity Wise Origin Bitcoin SHS
Grayscale Bitcoin Tr Btc Shs Rep Com Ut (GBTC)
Microstrategy Cl A New Put Option (MSTR)
Bitwise Bitcoin Etf Tr Shs Ben Int
Sarepta Therapeutics Put Option (SRPT)
Spdr Ser Tr S&p Biotech Put Option (XBI)
United States Steel Corporation (X)
NVIDIA Corporation Call Option (NVDA)
Cornerstone Strategic Value (CLM)
Amazon Put Option (AMZN)
Humana Call Option (HUM)
Amphenol Corp Cl A Put Option (APH)

View all positions for Boothbay Fund Management

Top funds holding Y Mabs Therapeutics

BlackRock
Paradigm Biocapital Advisors
Sofinnova Ventures
Vanguard Group
Point72 Asset Management
D. E. Shaw & Co
Pictet Asset Management Holding SA
Geode Capital Management
Acadian Asset Management
Caligan Partners
Soleus Capital Management
Dimensional Fund Advisors
Goldman Sachs Group
Boothbay Fund Management
Northern Trust

View all funds holding Y Mabs Therapeutics